ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Neuren Pharmaceuticals Ltd.
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Neuren Pharmaceuticals Limited (Neuren) is a New Zealand -based company. It is a biopharmaceutical company focusing on the development of drugs for neurological disorders, metabolism and cancer. The drugs target acute indications of brain injury, such as cognitive impairment resulting from cardiac surgery and traumatic brain injury, psychiatric symptoms of stroke, as well as chronic conditions, such as Parkinson’s and Alzheimer’s diseases. Neuren has three candidates: Motiva and NNZ-2566 are in clinical development to treat a range of acute and chronic neurological conditions, and NNZ-2591 is in preclinical development for Parkinson’s disease dementia and other chronic neurodegenerative conditions. The Company has operations in New Zealand and the United States.

Financial Summary
BRIEF: For the fiscal year ended 31 December 2011, Neuren Pharmaceuticals Limited's revenues decreased 30% to NZ$4.3M. Net loss decreased 5% to NZ$6.1M. Revenues reflect a decrease in income from United States Segment. Lower loss reflects a absence of loss on disposal of intangible asset, lower research & development costs and fall in patent costs. The Company is engaged in the development of drugs for neurological disorders.

Business Address


Level 2
AUCKLAND, NSW 1001
Phone: 64-9-3700200
Fax: 64-9-3617981
http://www.neurenpharma.com

ASX Share Price Information
Current Price 0.024
Current Price Date 22/05/2012
52 Week Hi/Low 0.04 - 0.01
Avg Volume Last ten Days 3.09
ASX Company Sizing
Market Cap 28.39
Revenues 20.80
EBITDA -4.67
Net Income -4.72
Number of Employees -
Enterprise Value 20.80
Research Analyst Forecast
Consensus Recommendation -
Target Price -
LT Growth Rate -
Projected P/E -
Sales -
EPS -
Profit -
DPS -
Share Ratios
EPS -0.00617
RPS 0.00436
BV per Share 0.00834
Cash per Share 0.00657
Cashflow per Share -0.00582
Cashflow per Share 0.00000
Financial Ratios
Gross Margin -
ROE -71.11447
Price/Sales 8.50734
P/E -
P/Book 2.87933